Polymorphisms in XPC, XPD and XPG DNA repair genes and leukemia risk in a Tunisian population

References

• Meenaghan T, Dowling M, Kelly M. Acute leukaemia: making sense of a complex blood cancer. Br J Nursing 2012;21:78–83.
   Google Scholar
• De Boer J, Walf-Vorderwülbecke V, Williams O. In focus: MLL-rearranged leukemia. Leukemia 2013;27:1224–1228.
   PubMed Web of Science ®Google Scholar
• Goldman JM, Melo JV. Chronic myeloid leukemia--advances in biology and new approaches to treatment. N Engl J Med 2003;349: 1451–164.
   PubMed Web of Science ®Google Scholar
• Pui CH, Relling MV, Downing JR, et al. Acute lymphoblastic leukemia. N Engl J Med 2004;350:1535–1548.
   PubMed Web of Science ®Google Scholar
• Brown BA. Hematology: principles and procedures. 6th ed. Philadelphia: Lea & Febiger; 1993.
   Google Scholar
• Advani AS, Hunger SP, Burnett AK. Acute leukemia in adolescents and young adults. Semin Oncol 2009;36:213–226.
   PubMed Web of Science ®Google Scholar
• Loeb KR, Loeb LA. Significance of multiple mutations in cancer. Carcinogenesis 2000;21:379–385.
   PubMed Web of Science ®Google Scholar
• Benhamou S, Sarasin A. Variability in nucleotide excision repair and cancer risk: a review. Mutat Res 2000;462:149–158.
   PubMed Web of Science ®Google Scholar
• Millar AL, Pal T, Madlensky L, et al. Mismatch repair gene defects contribute to the genetic basis of double primary cancers of the colorectum and endometrium. Hum Mol Genet 1999;8:823–829.
   PubMed Web of Science ®Google Scholar
• Rajewsky MF, Engelbergs J, Thomale J, et al. Relevance of DNA repair to carcinogenesis and cancer therapy. Recent Results Cancer Res 1998;154:127–146.
   PubMedGoogle Scholar
• Friedberg EC. How nucleotide excision repair protects against cancer. Nat Rev Cancer 2001;1:22–33.
   PubMed Web of Science ®Google Scholar
• Wood RD, Mitchell M, Sgouros J, et al. Human DNA repair genes. Science 2001;291:1284–1289.
   PubMed Web of Science ®Google Scholar
• Kamileri I, Karakasilioti I, Garinis GA. Nucleotide excision repair: new tricks with old bricks. Trends Genet 2012;28:566–573.
   PubMedGoogle Scholar
• Xi T, Jones IM, Mohrenweiser HW. Many amino acid substitution variants identified in DNA repair genes during human population screenings are predicted to impact protein function. Genomics 2004;83:970–979.
   PubMed Web of Science ®Google Scholar
• Vodicka P, Kumar R, Stetina R, et al. Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations and single-strand breaks in DNA. Carcinogenesis 2004;25:757–763.
   PubMed Web of Science ®Google Scholar
• Hu JJ, Mohrenweiser HW, Bell DA, et al. Symposium overview: genetic polymorphisms in DNA repair and cancer risk. Toxicol Appl Pharm 2002;185:64–73.
   PubMed Web of Science ®Google Scholar
• Bolufer P, Barragan E, Collado M, et al. Influence of genetic polymorphisms on the risk of developing leukemia and on disease progression. Leuk Res 2006;30:1471–1491.
   PubMed Web of Science ®Google Scholar
• Krajinovic M, Labuda D, Mathonnet G, et al. Polymorphisms in genes coding drugs and xenobiotic metabolizing enzymes, DNA repair enzymes, and response to treatment of childhood acute lymphoblastic leukemia. Clin Cancer Res 2002;8:802–810.
   PubMed Web of Science ®Google Scholar
• Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 2002;11:1513–1530.
   PubMed Web of Science ®Google Scholar
• de Laat WL, Jaspers NG, Hoeijmakers JH. Molecular mechanism of nucleotide excision repair. Genes Dev 1999;13:768–785.
   PubMed Web of Science ®Google Scholar
• Thoma BS, Vasquez KM. Critical DNA damage recognition functions of XPC-hHR23B and XPA-RPA in nucleotide excision repair. Mol Carcinog 2003;38:1–13.
   PubMed Web of Science ®Google Scholar
• Qiu L, Wang Z, Shi X, et al. Associations between XPC polymorphisms and risk of cancers: a meta-analysis. Eur J Cancer 2008;44:2241–2253.
   PubMed Web of Science ®Google Scholar
• He J, Shi TY, Zhu ML, et al. Associations of Lys939Gln and Ala499Val polymorphisms of the XPC gene with cancer susceptibility: a meta-analysis. Int J Cancer 2013;133:1765–1775.
   PubMed Web of Science ®Google Scholar
• Blankenburg S, König IR, Moessner R, et al. Assessment of 3 xeroderma pigmentosum group C gene polymorphisms and risk of cutaneous melanoma: a case control study. Carcinogenesis 2005;26:1085–1090.
   PubMed Web of Science ®Google Scholar
• Vogel U, Overvad K, Wallin H, et al. Combinations of polymorphisms in XPD, XPC and XPA in relation to risk of lung cancer. Cancer Lett 2005;222:67–74.
   PubMed Web of Science ®Google Scholar
• Jin B, Dong Y, Zhang X, et al. Association of XPC polymorphisms and lung cancer risk: a meta-analysis. PLoS One 2014;9:e93937.
   Google Scholar
• Wu Y, Jin M, Liu B, et al. The association of XPC polymorphisms and tea drinking with colorectal cancer risk in a Chinese population. Mol Carcinog 2011;50:189–198.
   PubMed Web of Science ®Google Scholar
• Rouissi K, Bahria IB, Bougatef K, et al. The effect of tobacco, XPC, ERCC2 and ERCC5 genetic variants in bladder cancer development. BMC Cancer 2011;11:101.
   PubMed Web of Science ®Google Scholar
• Dou K, Xu Q, Han X. The association between XPC Lys939Gln gene polymorphism and urinary bladder cancer susceptibility: a systematic review and meta-analysis. Diagn Pathol 2013;8:112.
   PubMed Web of Science ®Google Scholar
• Strom SS, Estey E, Outschoorn UM, et al. Acute myeloid leukemia outcome:role of nucleotide excision repair polymorphisms in intermediate risk patients. Leuk Lymphoma 2010;51:598–605.
   PubMed Web of Science ®Google Scholar
• Xu P, Chen B, Feng J, et al. Polymorphisms in XPC provide prognostic information in acute myeloid leukemia. Int J Hematol 2012;96:450–460.
   PubMed Web of Science ®Google Scholar
• Guillem VM, Cervantes F, Martínez J, et al. XPC genetic polymorphisms correlate with the response to imatinib treatment in patients with chronic phase chronic myeloid leukemia. Am J Hematol 2010;85:482–486.
   PubMed Web of Science ®Google Scholar
• Sugasawa K. XPC: its product and biological roles. Adv Exp Med Biol 2008;637:47–56.
   PubMed Web of Science ®Google Scholar
• Volker M, Moné MJ, Karmakar P, et al. Sequential assembly of the nucleotide excision repair factors in vivo. Mol Cell 2001;8:213–224.
   PubMed Web of Science ®Google Scholar
• Spitz MR, Wu X, Wang Y, et al. Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res 2001;61:1354– 1357.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Yang H, Chen Q, et al. Modulation of DNA damage/DNA repair capacity by XPC polymorphisms. DNA Repair 2008;7:141–148.
   PubMed Web of Science ®Google Scholar
• Schaeffer L, Moncollin V, Roy R, et al. The ERCC2/DNA repair protein is associated with the class II BTF2/TFIIH transcription factor. EMBO J 1994;13:2388–2392.
   PubMed Web of Science ®Google Scholar
• Reardon JT, Sancar A. Molecular anatomy of the human excision nuclease assembled at sites of DNA damage. Mol Cell Biol 2002;22: 5938–5959.
   PubMed Web of Science ®Google Scholar
• Egly JM. The 14th Data Lecture TFIIH, from transcription to clinic. FEBS Lett 2001;498:124–128.
   PubMed Web of Science ®Google Scholar
• Clarkson SG, Wood RD. Polymorphisms in the human XPD (ERCC2) gene, DNA repair capacity and cancer susceptibility: an appraisal. DNA Repair 2005;28:1068–1074.
   Web of Science ®Google Scholar
• Broughton BC, Steingrimsdottir H, Lehmann AR. Five polymorphisms in the coding sequence of the xeroderma pigmentosum group D gene. Mutat Res 1996;15:209–211.
   Web of Science ®Google Scholar
• Allan JM, Smith AG, Wheatley K, et al. Genetic variation in XPD predicts treatment outcome and risk of acute myeloid leukemia following chemotherapy. Blood 2004;104:3872–3877.
   PubMed Web of Science ®Google Scholar
• Liu D, Wu D, Li H, et al. The effect of XPD/ERCC2 Lys751Gln polymorphism on acute leukemia risk: a systematic review and meta-analysis. Gene 2014;538:209–216.
   PubMed Web of Science ®Google Scholar
• Mehta PA, Alonzo TA, Gerbing RB, et al. XPD Lys751Gln polymorphism in the etiology and outcome of childhood acute myeloid leukemia: a Children's Oncology Group report. Blood 2006;107:39–45.
   PubMed Web of Science ®Google Scholar
• Batar B, Güven M, Bariş S, et al. DNA repair gene XPD and XRCC1 polymorphisms and the risk of childhood acute lymphoblastic leukemia. Leuk Res 2009;33:759–763.
   PubMed Web of Science ®Google Scholar
• Pakakasama S, Sirirat T, Kanchanachumpol S, et al. Genetic polymorphisms and haplotypes of DNA repair genes in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 2007;48:16–20.
   PubMed Web of Science ®Google Scholar
• Ozdemir N, Celkan T, Barış S, et al. DNA repair gene XPD and XRCC1 polymorphisms and the risk of febrile neutropenia and mucositis in children with leukemia and lymphoma. Leuk Res 2012;36:565–569.
   PubMed Web of Science ®Google Scholar
• Ma H, Yu H, Liu Z, et al. Polymorphisms of XPG/ERCC5 and risk of squamous cell carcinoma of the head and neck. Pharmacogenet Genomics 2012;22:50–57.
   PubMed Web of Science ®Google Scholar
• Ding DP, He XF, Zhang Y. Lack of association between XPG Asp1104His and XPF Arg415Gln polymorphism and breast cancer risk: a meta-analysis of case-control studies. Breast Cancer Res Treat 2011;129:203–209.
   PubMed Web of Science ®Google Scholar
• Liu C, Yin Q, Hu J, et al. Quantitative assessment of the association between XPG Asp1104His polymorphism and bladder cancer risk. Tumour Biol 2014;35:1203–1209.
   PubMed Web of Science ®Google Scholar
• Zhu ML, Wang M, Cao ZG, et al. Association between the ERCC5 Asp1104His polymorphism and cancer risk: a meta-analysis. PLoS One 2012;7:e36293.
   Google Scholar
• Bhatia S, Sather HN, Heerema NA, et al. Racial and ethnic differences in survival of children with acute lymphoblastic leukemia. Blood 2002;100:1957–1964.
   PubMed Web of Science ®Google Scholar